Redox-responsive nanoparticles prevent post-ablation hepatocellular carcinoma recurrence by dual regulation of dendritic cells and tumor cells.
Radiofrequency ablation (RFA) is a locoregional therapy for hepatocellular carcinoma (HCC). However, the long-term efficacy for RFA is severely compromised by recurrence driven by an immunosuppressive tumor microenvironment (TME). In this study, we identify mature regulatory dendritic cells (mregDCs) as a key immune-re...